Corbus suspends ATM equity offering program, terminates Jan 29 prospectus supplement

Corbus Pharmaceuticals Holdings, Inc.

Suspended and terminated the ATM prospectus supplement dated Jan 29, 2024, under Sale Agreement with Jefferies.
No sales of common stock until a new prospectus supplement is filed.
The underlying Sale Agreement dated August 6, 2020, remains in full force and effect.

item 8.01

Corbus Pharmaceuticals Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-009086

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.